Breaking
RAPIDRECOVERY LIVE - RapidClaims completes its clean-claim-to-denial platform, April 2026 $11M RAISED - $8M Series A led by Accel, with Together Fund 6X GROWTH - RapidClaims expands sixfold in its first year 25+ SPECIALTIES - AI coding live across the platform, ~98% accuracy in radiology FROM VC TO FOUNDER - ChatGPT's 2022 launch pushed Dushyant Mishra to build
Dushyant Mishra, founder and CEO of RapidClaims
Profile / Healthtech Founder

Dushyant Mishra

He picked the least glamorous corner of US healthcare - medical billing - and is teaching machines to run it.

Founder & CEO, RapidClaims New York IIT Kharagpur - CFA

Fixing the money plumbing of healthcare

Dushyant Mishra runs RapidClaims from New York, where the company is building an AI-first platform for one of the least visible parts of American medicine: the revenue cycle. That is the machinery that turns a patient visit into a paid claim - coding, documentation, submission, and the long back-and-forth with insurers when a claim gets denied. It is slow, manual, and expensive. Mishra's bet is that most of it can be run by software.

RapidClaims sits across that whole cycle. Its products read clinical notes and assign medical codes, flag gaps in documentation, scrub claims before they go out, and now, with a 2026 product called RapidRecovery, chase down denials with a mix of automation and voice AI. The company says it is live across more than 25 specialties, with high autonomous accuracy in over 20 of them, and around 98 percent accuracy in areas like radiology and anesthesia. Providers using it, the company says, can cut costs by up to 70 percent and shorten timelines from months to weeks.

The framing Mishra keeps coming back to is scale. US healthcare carries an administrative bill he pegs at roughly $353 billion, and he cites estimates that AI could remove around $168 billion of it. "RCM is genuinely the first administrative area where AI is really reducing workload rather than adding more clicks," he has said - a pointed contrast with the reputation software has earned in hospitals for making clinicians' days longer, not shorter.

He is deliberate about not building a single tool. "Point solutions are ineffective," he argues, pushing instead for what he calls an all-encompassing platform strategy. The reasoning is practical: a hospital that buys one vendor for coding, another for denials, and a third for documentation ends up with the same fragmentation it started with. RapidClaims wants to be the connected layer underneath all of it.

$11MTotal raised
6xYear-one growth
25+Specialties live
~98%Radiology accuracy

Denial management was never a question of if for RapidClaims. It was a question of when.

- Dushyant Mishra, 2026
The Path

Operator, then investor, then founder

Mishra did not arrive at healthcare AI from a research lab. He trained as an engineer at IIT Kharagpur, taking a dual degree that combined a four-year B.Tech with an integrated master's, and he later earned a CFA charter - an unusual pairing of builder and finance discipline.

From 2016 to 2021 he was inside the industry he now sells to, at Abbott, where he held roles in strategy and commercial operations, including a stint leading strategic projects and commercial operations across South Asia. That is where he says he learned how the financial fault lines in healthcare actually run.

He then spent two years, from 2021 to 2023, as an early-stage investor at Together Fund, working with founders trying to build global companies. What tipped him from evaluating startups to starting one was the release of ChatGPT in late 2022. Together Fund asked him to incubate what became RapidClaims, and he left to run it.

He built it with two co-founders he trusted: Abhinay Vyas, a data scientist who had worked at Novartis, and Jot Sarup Singh, formerly of Postman and Goldman Sachs. Together they aimed at a global revenue cycle management market measured in the hundreds of billions of dollars.

2016 - 2021
Strategy & commercial operations roles at Abbott, including leading projects across South Asia.
2021 - 2023
Early-stage investor at Together Fund, working with founders building global companies.
2023
Co-founds RapidClaims with Abhinay Vyas and Jot Sarup Singh; incubated at Together Fund.
2024
Launches the AI medical coding platform out of beta on a $3M seed round.
2025
Closes an $8M Series A led by Accel; total funding reaches about $11M.
2026
Ships RapidRecovery, completing an integrated revenue cycle platform.
The Platform

One connected revenue cycle

Coding

RapidCode

Autonomous medical coding across 20+ specialties, reading clinical notes and assigning accurate codes.

Documentation

RapidCDI

Clinical documentation improvement that flags gaps before they turn into revenue leakage.

Prevention

RapidScrub

AI claim pre-screening that catches errors and reduces denials before submission.

Recovery

RapidRecovery

Denial management with root-cause analysis and voice AI for autonomous payer follow-up.

The Case

Why the numbers matter

The scale Mishra is chasing

US healthcare administration, as cited by RapidClaims

Admin bill
$353B
AI-addressable
~$168B
Cost cut for providers
up to 70%
Coding accuracy
~98%

Figures are company and cited-expert estimates, not independently audited.

In His Words

How he talks about the work

"Our approach goes beyond automation. We aim to enhance the efficiency and accuracy of medical coding, which is fundamental in reducing claim denials and improving the financial health of healthcare providers."

"Redesigning workflows, simplifying RCM processes, trimming codes, realigning incentives: all of it can be aided through purposeful AI."

"Our multi-specialty AI solution offers a distinct advantage over narrow, specialty-focused tools."

"RCM is genuinely the first administrative area where AI is really reducing workload rather than adding more clicks."

Worth Knowing

A few things that stand out

01

He holds both an engineering dual degree from IIT Kharagpur and a CFA charter - rare training as builder and financier at once.

02

RapidClaims was incubated inside Together Fund, the venture firm where Mishra had been an investor.

03

Early angels include healthcare and startup leaders such as Oscar Benavidez of Mass General and Ankit Jain, CEO of Infinitus.

04

Customers include major physician groups and federally qualified health centers, with integrations across 15+ EHR systems.

05

His stated aim is to help healthcare feel "patient-centered and physician-caring" again by clearing administrative waste.

06

The single moment he credits for the pivot: the public release of ChatGPT in late 2022.

Redesigning workflows, simplifying RCM processes, trimming codes, realigning incentives - all of it can be aided through purposeful AI.

- Dushyant Mishra on the road back to patient-centered care
Questions

The quick answers

Who is Dushyant Mishra?
He is the founder and CEO of RapidClaims, a New York-based company building an AI platform for healthcare revenue cycle management. He previously worked at Abbott and as an early-stage investor at Together Fund.
What is RapidClaims?
An AI-first revenue cycle management platform that automates medical coding, clinical documentation, claim scrubbing and denial recovery for US healthcare providers, founded in 2023.
How much has RapidClaims raised?
About $11 million total, including an $8 million Series A led by Accel with participation from Together Fund, plus an earlier $3 million seed round.
Who co-founded RapidClaims with him?
Abhinay Vyas, a data scientist who worked at Novartis, and Jot Sarup Singh, who previously worked at Postman and Goldman Sachs.
Where did he study?
He earned a dual degree in engineering from IIT Kharagpur and also holds a CFA charter.